CD4 and HIV infectious disease: At a minimum, HIV infection per se should not be an exclusion criterion, and people living with HIV with suppressed viral load and immune reconstitution (CD4+ T cell count >200/μL) could reasonably be included in clinical and/or pivotal trials.